CoChat

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

Noto, Yu-Ichi, Shibuya, Kazumoto, Sato, Yasunori, Kanai, Kazuaki, Misawa, Sonoko, Sawai, Setsu, Mori, Masahiro, Uchiyama, Tomoyuki, Isose, Sagiri, Nasu, Saiko, Sekiguchi, Yukari, Fujimaki, Yumi, Kasai, Takashi, Tokuda, Takahiko, Nakagawa, Masanori, Kuwabara, Satoshi · 2011 · Amyotrophic Lateral Sclerosis
Cited by 113

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

TAR DNA binding protein of 43 kDa (TDP-43) is likely to be the major pathogenetic protein in amyotrophic lateral sclerosis (ALS). A previous study has shown that levels of TDP-43 in CSF measured by an ELISA are significantly higher for ALS patients than for controls. The aim of this study was to investigate whether elevated CSF TDP-43 levels are specific to ALS, and are associated with clinical profiles in ALS patients. We measured CSF TDP-43 levels by the same ELISA in 27 ALS patients and 50 neurodegenerative or inflammatory disease controls such as Parkinson's disease, multiple sclerosis, and Guillain-Barré syndrome. Results showed that the CSF TDP-43 levels were increased only in ALS patients. Receiver operating characteristic (ROC) analyses showed a sensitivity of 59.3% and a specificity of 96.0%. We also found that lower CSF TDP-43 levels may be associated with shorter survival time. In conclusion, the CSF TDP-43 is a potential biomarker that supports a diagnosis of ALS. Moreover, among ALS patients, lower levels of CSF TDP-43 may reflect the accumulation of TDP-43 in the cortical and spinal motor neurons and thereby shorter survival time, although this should be confirmed in larger prospective studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/17482968.2010.541263

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 113

Metadata

Authors
Noto, Y.-I., Shibuya, K., Sato, Y., Kanai, K., Misawa, S., Sawai, S., Mori, M., Uchiyama, T., Isose, S., Nasu, S., Sekiguchi, Y., Fujimaki, Y., Kasai, T., Tokuda, T., Nakagawa, M., & Kuwabara, S.
Venue
Amyotrophic Lateral Sclerosis
Published
2010-12-02
Volume
12
Issue
2
Pages
140-143
ISSN
  • 1471-180X (ISSN-L)
  • 1748-2968
OpenAlex
W2096075172
Cited by
113
References
5
FWCI
3.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value. https://app.cochat.ai/papers/10.3109/17482968.2010.541263
The paper
Noto, Y.-I., Shibuya, K., Sato, Y., Kanai, K., Misawa, S., Sawai, S., Mori, M., Uchiyama, T., Isose, S., Nasu, S., Sekiguchi, Y., Fujimaki, Y., Kasai, T., Tokuda, T., Nakagawa, M., & Kuwabara, S. (2011). Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value. Amyotrophic Lateral Sclerosis. https://doi.org/10.3109/17482968.2010.541263

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.